FormulaFolio Investments’s Bristol-Myers Squibb BMY Stock Holding History

FormulaFolio Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$5K	Hold	80	–	–	﹤0.01%	335
2021 Q1	$5K	Sell	80 -57,818	-100%	-$3.6M	﹤0.01%	338
2020 Q4	$3.59M	Buy	57,898 +46,101	+391%	+$2.83M	0.08%	188
2020 Q3	$711K	Sell	11,797 -795	-6%	-$47.8K	0.03%	174
2020 Q2	$740K	Buy	12,592 +3,929	+45%	+$235K	0.03%	159
2020 Q1	$483K	Sell	8,663 -110	-1%	-$6.72K	0.03%	177
2019 Q4	$563K	Buy	8,773 +1,605	+22%	+$91.9K	0.02%	232
2019 Q3	$363K	Sell	7,168 -194	-3%	-$9.12K	0.01%	254
2019 Q2	$334K	Sell	7,362 -1,311	-15%	-$61.1K	0.01%	257
2019 Q1	$414K	Sell	8,673 -5,710	-40%	-$284K	0.02%	221
2018 Q4	$893K	Hold	14,383	–	–	0.04%	149
2018 Q3	$893K	Sell	14,383 -1,966	-12%	-$117K	0.04%	149
2018 Q2	$905K	Buy	16,349 +8,324	+104%	+$450K	0.04%	137
2018 Q1	$508K	Buy	8,025 +1,619	+25%	+$104K	0.03%	173
2017 Q4	$393K	Buy	6,406 +611	+11%	+$38.2K	0.03%	194
2017 Q3	$369K	Buy	5,795 +778	+16%	+$45.4K	0.03%	168
2017 Q2	$280K	Buy	5,017 +768	+18%	+$41.8K	0.03%	174
2017 Q1	$231K	Buy	+4,249	New	+$233K	0.03%	194

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

FormulaFolio Investments's BMY Position: Q2 2021 in Review

FormulaFolio Investments held its Bristol-Myers Squibb (BMY) position steady in Q2 2021 at 80 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #335.

FormulaFolio Investments first reported a position in BMY in Q1 2017 and has held it in 18 quarters since. The position peaked at $3.59M in Q4 2020. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

FormulaFolio Investments held 80 shares of Bristol-Myers Squibb worth $5K as of Q2 2021.
FormulaFolio Investments left its Bristol-Myers Squibb share count unchanged in Q2 2021.
Bristol-Myers Squibb made up ﹤0.01% of FormulaFolio Investments's portfolio in Q2 2021, its #335 holding.
FormulaFolio Investments first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 18 quarters since.
FormulaFolio Investments's Bristol-Myers Squibb position peaked at $3.59M in Q4 2020.
2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on FormulaFolio Investments's 13F filing for Q2 2021, filed 28 Jul 2021.